INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (105857, 3579, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, X'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', NULL, NULL, X'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', 'NCBI', 1768159686, 1768159686, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (105858, 3579, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c9590cd0ac23010845fa5e46c6d2cd66a6edef4e0a9de544a5a170da64949b6fe2079779b6a410f0ade66663f6660ef646f9a43ae780584056469b422838034467a7b44ac2d8ba28b384135d4e6e095887aca9686d7b0cf397a38a6f124a4a37044d7346549c2c6d3219dc5499a762c9428b4b22d79274b8546770ae18afd709035752da10285dcb35bd5a56b7d15a5c0dbf6b9d914ef55ae8d901712bcdbec5a27853a3d8dbf6500f95cdacfb105f0f32d58017269ffebfcdef1fb631d9dbf68b773ce3d00ab2e7959', NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', 'Hybrid', 1768159686, 1768159686, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (105859, 3579, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', 'NCBI', 1768159686, 1768159686, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (105860, 3579, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'789c1dcbd10d80200c45d155de04cee20a0d16690294b48d86ed053f6f72ee59999c619cd9108a288c221e6a13d42f8c325d12550cb510edd0bc8c386865aabc1fe347f8fdd7a46dd4e537f56d1bf59bba783b3e3d9a279a', NULL, X'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', X'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', NULL, X'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', 'NCBI', 1768159686, 1768159686, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (105861, 3579, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c558f316e03410845fb9c8203ac2c1739411a77be40e482996137280cac18c6966f93b3e464c64a1377f005bcc7798673b0290aece8d829c8078c2f9bd2a01074530e736ae0b44d41973be09a4350d01973bbc298be91df1760ad321beb061f70e5c0ce3a327553406d108e9580843a698c039c48c9132c586ee6dfffa8ab89d82da1a83a51e4e5b6f035f1ebd4fa1487a01149a9d677497b2862d6b29d1a4b4a8e14ccafb09864b5a3922c4f9bdf1fe19ddb5f7278fb7c3f5e1e831a6454', NULL, NULL, X'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', 'NCBI', 1768159686, 1768159686, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (105862, 3579, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c558f316e03410845fb9c8203ac2c1739411a77be40e482996137280cac18c6966f93b3e464c64a1377f005bcc7798673b0290aece8d829c8078c2f9bd2a01074530e736ae0b44d41973be09a4350d01973bbc298be91df1760ad321beb061f70e5c0ce3a327553406d108e9580843a698c039c48c9132c586ee6dfffa8ab89d82da1a83a51e4e5b6f035f1ebd4fa1487a01149a9d677497b2862d6b29d1a4b4a8e14ccafb09864b5a3922c4f9bdf1fe19ddb5f7278fb7c3f5e1e831a6454', NULL, NULL, X'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', 'NCBI', 1768159686, 1768159686, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (105863, 3579, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c558f316e03410845fb9c8203ac2c1739411a77be40e482996137280cac18c6966f93b3e464c64a1377f005bcc7798673b0290aece8d829c8078c2f9bd2a01074530e736ae0b44d41973be09a4350d01973bbc298be91df1760ad321beb061f70e5c0ce3a327553406d108e9580843a698c039c48c9132c586ee6dfffa8ab89d82da1a83a51e4e5b6f035f1ebd4fa1487a01149a9d677497b2862d6b29d1a4b4a8e14ccafb09864b5a3922c4f9bdf1fe19ddb5f7278fb7c3f5e1e831a6454', NULL, NULL, X'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', 'NCBI', 1768159686, 1768159686, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (105864, 3579, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c558f316e03410845fb9c8203ac2c1739411a77be40e482996137280cac18c6966f93b3e464c64a1377f005bcc7798673b0290aece8d829c8078c2f9bd2a01074530e736ae0b44d41973be09a4350d01973bbc298be91df1760ad321beb061f70e5c0ce3a327553406d108e9580843a698c039c48c9132c586ee6dfffa8ab89d82da1a83a51e4e5b6f035f1ebd4fa1487a01149a9d677497b2862d6b29d1a4b4a8e14ccafb09864b5a3922c4f9bdf1fe19ddb5f7278fb7c3f5e1e831a6454', NULL, NULL, X'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', 'NCBI', 1768159686, 1768159686, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (105865, 3579, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c558f316e03410845fb9c8203ac2c1739411a77be40e482996137280cac18c6966f93b3e464c64a1377f005bcc7798673b0290aece8d829c8078c2f9bd2a01074530e736ae0b44d41973be09a4350d01973bbc298be91df1760ad321beb061f70e5c0ce3a327553406d108e9580843a698c039c48c9132c586ee6dfffa8ab89d82da1a83a51e4e5b6f035f1ebd4fa1487a01149a9d677497b2862d6b29d1a4b4a8e14ccafb09864b5a3922c4f9bdf1fe19ddb5f7278fb7c3f5e1e831a6454', NULL, NULL, X'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', 'NCBI', 1768159686, 1768159686, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (105866, 3579, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c558f316e03410845fb9c8203ac2c1739411a77be40e482996137280cac18c6966f93b3e464c64a1377f005bcc7798673b0290aece8d829c8078c2f9bd2a01074530e736ae0b44d41973be09a4350d01973bbc298be91df1760ad321beb061f70e5c0ce3a327553406d108e9580843a698c039c48c9132c586ee6dfffa8ab89d82da1a83a51e4e5b6f035f1ebd4fa1487a01149a9d677497b2862d6b29d1a4b4a8e14ccafb09864b5a3922c4f9bdf1fe19ddb5f7278fb7c3f5e1e831a6454', NULL, NULL, X'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', 'NCBI', 1768159686, 1768159686, NULL, NULL, NULL, NULL, NULL, NULL, NULL);